Related Experiment Videos
Rational antibacterial vaccine design through genomic technologies
1Biochemistry and Molecular Biology Unit, Chiron S.r.l., Via Fiorentina 1, 53100 Siena, Italy. guido_grandi@chiron.it
International Journal for Parasitology
|June 5, 2003
Summary
Genomic technologies like bioinformatics and transcriptomics accelerate vaccine development. New vaccine candidates against Meningococcus B and Chlamydia pneumoniae were identified using high-throughput methods.
Area of Science:
- Vaccinology and infectious disease research.
- Application of genomics and proteomics in vaccine discovery.
Background:
- Vaccinology is effective but lacks vaccines for several pathogens.
- Genomic technologies offer promising advancements for vaccinology.
Purpose of the Study:
- To review the potential of genomics technologies in vaccine development.
- To illustrate research on identifying novel vaccine candidates.
Main Methods:
- In silico genome analysis and transcriptome analysis for Meningococcus B antigen selection.
- High-throughput cloning, expression, and 2D gel/mass spectrometry for Chlamydia pneumoniae subproteome analysis.
Main Results:
- Identification of potential vaccine candidates against Meningococcus B.
- Elucidation of Chlamydia pneumoniae surface protein subproteome and identification of candidates.
Conclusions:
- Genomic technologies significantly enhance the discovery of new vaccine candidates.
- High-throughput approaches are crucial for advancing vaccinology.